BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33106212)

  • 1. Development and Assessment of Two Highly Pathogenic Avian Influenza (HPAI) H5N6 Candidate Vaccine Viruses for Pandemic Preparedness.
    Liu LQ; Li Z; Jiao M; Lu J; Zhou JF; Li XY; Liu J; Guo JF; Xiao N; Zhao X; Wang DY
    Biomed Environ Sci; 2020 Sep; 33(9):670-679. PubMed ID: 33106212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single Amino Acid Substitution at Residue 218 of Hemagglutinin Improves the Growth of Influenza A(H7N9) Candidate Vaccine Viruses.
    Li X; Gao Y; Ye Z
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31270231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development.
    Liu L; Lu J; Li Z; Zhou J; Guo J; Li X; Liu J; Shu Y; Wang D
    Hum Vaccin Immunother; 2018 Mar; 14(3):532-539. PubMed ID: 29300686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosafety risk assessment for production of candidate vaccine viruses to protect humans from zoonotic highly pathogenic avian influenza viruses.
    Chen LM; Donis RO; Suarez DL; Wentworth DE; Webby R; Engelhardt OG; Swayne DE
    Influenza Other Respir Viruses; 2020 Mar; 14(2):215-225. PubMed ID: 31659871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    Li J; Hou G; Wang Y; Wang S; Cheng S; Peng C; Jiang W
    J Gen Virol; 2018 Dec; 99(12):1600-1607. PubMed ID: 30358528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells.
    Tzeng TT; Chen PL; Weng TC; Tsai SY; Lai CC; Chou HI; Chen PW; Lu CC; Liu MT; Sung WC; Lee MS; Hu AY
    J Biomed Sci; 2020 Apr; 27(1):47. PubMed ID: 32241276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genesis and Dissemination of Highly Pathogenic H5N6 Avian Influenza Viruses.
    Yang L; Zhu W; Li X; Bo H; Zhang Y; Zou S; Gao R; Dong J; Zhao X; Chen W; Dong L; Zou X; Xing Y; Wang D; Shu Y
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28003485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a new candidate H5N1 avian influenza virus for pre-pandemic vaccine production.
    Dong J; Matsuoka Y; Maines TR; Swayne DE; O'Neill E; Davis CT; Van-Hoven N; Balish A; Yu HJ; Katz JM; Klimov A; Cox N; Li DX; Wang Y; Guo YJ; Yang WZ; Donis RO; Shu YL
    Influenza Other Respir Viruses; 2009 Nov; 3(6):287-95. PubMed ID: 19903211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, epidemiological and virological characteristics of the first detected human case of avian influenza A(H5N6) virus.
    Zhang R; Chen T; Ou X; Liu R; Yang Y; Ye W; Chen J; Yao D; Sun B; Zhang X; Zhou J; Sun Y; Chen F; Wang SP
    Infect Genet Evol; 2016 Jun; 40():236-242. PubMed ID: 26973295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective efficacy of an inactivated chimeric H7/H5 avian influenza vaccine against highly pathogenic avian influenza H7N9 and clade 2.3.4.4 H5 viruses.
    Peng C; Hou G; Li J; Wang S; Wang Y; Cheng S; Yu X; Jin J; Jiang W
    Vet Microbiol; 2018 Sep; 223():21-26. PubMed ID: 30173747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic relationship between poultry and wild bird viruses during the highly pathogenic avian influenza H5N6 epidemic in the Netherlands, 2017-2018.
    Beerens N; Heutink R; Pritz-Verschuren S; Germeraad EA; Bergervoet SA; Harders F; Bossers A; Koch G
    Transbound Emerg Dis; 2019 May; 66(3):1370-1378. PubMed ID: 30874364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of H5N6 highly pathogenic avian influenza viruses isolated from wild and captive birds in the winter season of 2016-2017 in Northern Japan.
    Hiono T; Okamatsu M; Matsuno K; Haga A; Iwata R; Nguyen LT; Suzuki M; Kikutani Y; Kida H; Onuma M; Sakoda Y
    Microbiol Immunol; 2017 Sep; 61(9):387-397. PubMed ID: 28815716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Novel Reassortant Influenza A(H5N6) Viruses in Poultry and Humans, China, 2021.
    Jiang W; Dong C; Liu S; Peng C; Yin X; Liang S; Zhang L; Li J; Yu X; Li Y; Wang J; Hou G; Zeng Z; Liu H
    Emerg Infect Dis; 2022 May; 28(5):1064-1066. PubMed ID: 35447059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
    Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
    Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2012 Mar; 87(11):97-108. PubMed ID: 22462204
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs.
    Ridenour C; Johnson A; Winne E; Hossain J; Mateu-Petit G; Balish A; Santana W; Kim T; Davis C; Cox NJ; Barr JR; Donis RO; Villanueva J; Williams TL; Chen LM
    Influenza Other Respir Viruses; 2015 Sep; 9(5):263-70. PubMed ID: 25962412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2014 Mar; 89(11):105-15. PubMed ID: 24707515
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
    Wkly Epidemiol Rec; 2013 Oct; 88(42):449-63. PubMed ID: 24159668
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and evaluation of an Influenza virus subtype H7N2 vaccine candidate for pandemic preparedness.
    Pappas C; Matsuoka Y; Swayne DE; Donis RO
    Clin Vaccine Immunol; 2007 Nov; 14(11):1425-32. PubMed ID: 17913860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.